Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
CHRETO ApS
APS
Active
CVR 33382170
Slotsmarken 18, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2010 · 15 years old
6 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CHRETO ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
JK
Jan Kyhse-Andersen
Chief Executive Officer
Chief Executive Officer
2011
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (5)
KB
Kim Bjørnstrup
Chairman
Chairman
2018
FB
Frank Bech Nygaard
Board of Directors
Board of Directors
2020
AW
Anders Wikström
Board of Directors
Board of Directors
2024
LI
Lars Ivar Bäckman
Board of Directors
Board of Directors
2018
SW
Susanne Wetterlin
Board of Directors
Board of Directors
2016
Former (5)
MA
Mario Augusto Marques Da Silva Maia
Board of Directors
Board of Directors
2020 – 2023
MB
Mikael Bundgaard-Nielsen
Board of Directors
Board of Directors
2016 – 2020
SE
Svend Erik Licht
Chairman
Chairman
2016 – 2016
GW
Geert W Nygaard
Chairman
Chairman
2014 – 2014
TV
Torben Vedel Stahl Jørgensen
Chairman
Chairman
2014 – 2016
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Brohuvudet AB
Individual
15–19.99%
15–19.99%
2025
JAN KYHSE-ANDERSEN HOLDING ApS
Company
10–14.99%
10–14.99%
2023
Näset Rådmansö AB
Individual
10–14.99%
10–14.99%
2021
NOVOZYMES A/S
Company
5–9.99%
5–9.99%
2022
MDSH Tech ApS
Company
5–9.99%
5–9.99%
2025
SKEIKAMPEN INVEST ApS
Company
5–9.99%
5–9.99%
2020
Biotage AB
Individual
5–9.99%
5–9.99%
2025
S+J LICHT ApS
Company
5–9.99%
5–9.99%
2013
TOLUHA ApS
Company
5–9.99%
5–9.99%
2013
Geert Walther Nygaard
Individual
5–9.99%
5–9.99%
2013
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CHRETO ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network